Hematoma Following Primary Total Hip Arthroplasty: A Grave Complication

S. M.Javad Mortazavi, Patricia Hansen, Benjamin Zmistowski, Patrick W. Kane, Camilo Restrepo, Javad Parvizi

Research output: Contribution to journalArticlepeer-review

42 Scopus citations


Hematoma following primary total hip arthroplasty (THA) can require a return to the operating room. The purpose of this study was to uncover risk factors for hematoma and how it affects the outcome of THA. This case-control study identified 38 patients requiring reoperation due to hematoma following THA between 2000 and 2007. The 38 patients were matched with 117 patients without hematoma. The mean follow-up was 4.1. years (range, 2.1-9.6). Multivariate regression showed that blood loss, administration of fresh frozen plasma and Vitamin K, perioperative anticoagulation and hormonal therapy were independent predictors for hematoma formation. Chronic anticoagulation and autologous blood transfusion were independent risk factors for mortality. Hematoma itself was found to be an independent risk factor for adverse outcomes, increasing morbidity and mortality, despite adequate treatment.

Original languageEnglish
Pages (from-to)498-503
Number of pages6
JournalJournal of Arthroplasty
Issue number3
StatePublished - Mar 2013


  • Complications
  • Hematoma
  • Total hip arthroplasty


Dive into the research topics of 'Hematoma Following Primary Total Hip Arthroplasty: A Grave Complication'. Together they form a unique fingerprint.

Cite this